• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Idera Pharmaceuticals Inc

+ Add to Watchlist

HXXA:GR

2.113 EUR 0.003 0.14%

As of 13:48:00 ET on 08/27/2014.

Snapshot for Idera Pharmaceuticals Inc (HXXA)

Open: 2.185 Day's Range: 2.113 - 2.195 Volume: 0
Previous Close: 2.110 52wk Range: 1.119 - 5.000 1-Yr Rtn: +43.25%

Stock Chart for HXXA

No chart data available.
  • HXXA:GR 2.113
  • 1D
  • 1M
  • 1Y
2.110
Interactive HXXA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HXXA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4400
Est. PEG Ratio -
Market Cap (M EUR) 177.00
Shares Outstanding (M) 83.77
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HXXA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HXXA

Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.

Sudhir D Agrawal "Phil"President/CEOLouis J Arcudi IIISenior VP/CFO/Treasurer/Secy
Louis BrennerSenior VP/Chief Medical OfcrRobert D ArbeitVP:Clinical Development
More Company Profile & Key Executives for HXXA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil